Dr. Krishnendu Roy, Ph.D.

Director, NSF Engineering Research Center (ERC) for Cell Manufacturing Technologies (CMaT)
Georgia Institute of Technology

Krishnendu (Krish) Roy holds several appointments at Georgia Tech: Robert A. Milton Chair Professor at the Wallace H. Coulter Department of Biomedical Engineering, director of the NSF Engineering Research Center (ERC) for Cell Manufacturing Technologies (CMaT); director of the Marcus Center for Cell-Therapy Characterization and Manufacturing (MC3M); and director of the Center for ImmunoEngineering.

Roy received his undergraduate degree from the Indian Institute of Technology (India) followed by his M.S. in biomedical engineering from Boston University and his Ph.D. in biomedical engineering from Johns Hopkins University. After completing his Ph.D., he joined Zycos Inc., a start-up biotechnology company where he served first as a scientist and then as a senior scientist in the Drug Delivery Research group.

Roy left industry to join The University of Texas at Austin in 2002, where he was professor and Fellow of the Cockrell Chair in Engineering Excellence. He left UT-Austin in July of 2013 to move to Georgia Tech.

Roy's research interests are in the areas of immunoengineering, cell manufacturing, controlled drug and vaccine delivery technologies and stem cell engineering. His work is at the interface of biomaterials and the immune system, with applications in cancer, infectious diseases and immunotherapies. In recognition of his seminal contribution to these fields, Roy has been elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and Fellow of the Biomedical Engineering Society (BMES).

Roy's research has been supported through numerous grants from the NIH and NSF and several foundations. He serves as a member of the editorial boards of the Journal of Controlled Release, the European Journal of Pharmaceutics and Biopharmaceutics and the Journal of Immunology and Regenerative Medicine, all from Elsevier; and the AIChE Journal of Advanced Biomanufacturing and Bioprocessing. He is a member of the Forum on Regenerative Medicine of the National Academies of Science, Engineering and Medicine (NASEM), and a board member of the Standards Coordinating Body (SCB) for Cell and Regenerative Therapies.